FORCESI, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 553
EU - Europa 332
AS - Asia 239
AF - Africa 51
OC - Oceania 2
Totale 1.177
Nazione #
US - Stati Uniti d'America 552
IT - Italia 86
VN - Vietnam 74
GB - Regno Unito 71
SG - Singapore 68
CN - Cina 58
DE - Germania 53
SE - Svezia 44
TG - Togo 29
IN - India 20
IE - Irlanda 15
CI - Costa d'Avorio 13
RU - Federazione Russa 12
BG - Bulgaria 10
JO - Giordania 10
BE - Belgio 9
FR - Francia 9
FI - Finlandia 6
ZA - Sudafrica 6
EE - Estonia 4
AT - Austria 3
AU - Australia 2
ID - Indonesia 2
IR - Iran 2
NG - Nigeria 2
RO - Romania 2
UZ - Uzbekistan 2
CA - Canada 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
PL - Polonia 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.177
Città #
Chandler 67
Southend 66
Singapore 59
Fairfield 57
Dong Ket 52
Ashburn 40
Bologna 29
Lomé 29
Wilmington 28
Houston 27
Cambridge 26
Santa Clara 26
Seattle 23
Ann Arbor 22
Woodbridge 21
Princeton 20
Dublin 15
Abidjan 13
Boardman 12
Beijing 11
Berlin 11
Turin 11
Amman 10
Redmond 10
Sofia 10
Brussels 9
Florence 9
Bremen 7
Westminster 7
Helsinki 6
Saint Petersburg 6
Nanjing 5
Rome 5
Des Moines 4
Falls Church 4
Hebei 4
New York 4
San Diego 4
Cesena 3
Gunzenhausen 3
Hangzhou 3
Los Angeles 3
Phoenix 3
Shanghai 3
Vienna 3
Wuhan 3
Abeokuta 2
Adelaide 2
Biella 2
Changsha 2
Fabriano 2
Forlì 2
Jakarta 2
Jinan 2
Kunming 2
London 2
Medford 2
Nanchang 2
San Jose 2
Zhengzhou 2
Andover 1
Atlanta 1
Brescia 1
Bühl 1
Cairo 1
Castelnuovo Rangone 1
Chengdu 1
Copenhagen 1
Copparo 1
Dearborn 1
Dongguan 1
Esslingen am Neckar 1
Frankfurt Am Main 1
Fremont 1
Guangzhou 1
Haikou 1
Imola 1
Kartal 1
La Canada Flintridge 1
Langfang 1
Lanzhou 1
Las Vegas 1
Logroño 1
Milan 1
Montemaggiore Al Metauro 1
Munich 1
Orlando 1
Padova 1
Pomezia 1
Pune 1
Queens 1
Québec 1
Sacramento 1
San Francisco 1
Shenyang 1
Taizhou 1
Tianjin 1
Torino 1
Toyama 1
Varese 1
Totale 861
Nome #
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 207
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 176
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 132
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 130
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 127
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 112
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 95
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 87
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 79
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 60
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 14
Totale 1.219
Categoria #
all - tutte 3.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 0 21 21 22 34 28 21 5 11
2020/2021153 22 13 3 3 0 1 4 14 16 9 8 60
2021/2022260 54 3 14 7 26 25 10 14 14 10 57 26
2022/2023308 21 44 15 42 22 23 18 21 46 16 31 9
2023/202483 7 13 8 11 7 19 1 5 0 5 7 0
2024/2025164 31 51 30 16 36 0 0 0 0 0 0 0
Totale 1.219